Literature DB >> 21860686

Complete clinical response of liver metastasis after chemotherapy: To resect or not?

Jose M Ramia-Angel1, Roberto De la Plaza, Jose E Quiñones.   

Abstract

This paper aims to update the therapeutical strategies in liver metastasis with complete clinical response (CCR) after chemotherapy and to determine if surgery is always necessary after CCR. The aim of chemotherapy is to achieve a good clinical response rather than CCR of liver metastasis. The CCR of liver metastasis after chemotherapy cannot be considered synonymous with a cure. The resection of the hepatic segment where there was hepatic metastases with CCR after chemotherapy theoretically prevents recurrence, improves survival and makes it possible to confirm whether there has been a complete pathological response. However, the medical literature about this topic is scarce and sometimes contradictory.

Entities:  

Keywords:  Chemotherapy; Clinical response; Liver; Metastasis; Surgery

Year:  2011        PMID: 21860686      PMCID: PMC3158860          DOI: 10.4251/wjgo.v3.i7.107

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  17 in total

1.  The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists.

Authors:  A R Padhani; L Ollivier
Journal:  Br J Radiol       Date:  2001-11       Impact factor: 3.039

2.  Pathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapy.

Authors:  Gabriel Chan; Mazen Hassanain; Prosanto Chaudhury; Dionisios Vrochides; Amy Neville; Matthew Cesari; Petr Kavan; Victoria Marcus; Peter Metrakos
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

3.  Disappearing colorectal liver metastases after chemotherapy: should we be concerned?

Authors:  Mark G van Vledder; Mechteld C de Jong; Timothy M Pawlik; Richard D Schulick; Luis A Diaz; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2010-09-14       Impact factor: 3.452

4.  Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.

Authors:  Yoji Kishi; Daria Zorzi; Carlo M Contreras; Dipen M Maru; Scott Kopetz; Dario Ribero; Manuela Motta; Nicoletta Ravarino; Mauro Risio; Steven A Curley; Eddie K Abdalla; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2010-06-22       Impact factor: 5.344

5.  Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

Authors:  Stéphane Benoist; Antoine Brouquet; Christophe Penna; Catherine Julié; Mostafa El Hajjam; Sophie Chagnon; Emmanuel Mitry; Philippe Rougier; Bernard Nordlinger
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

6.  Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases.

Authors:  Kuniya Tanaka; Hideki Takakura; Kazuhisa Takeda; Kenichi Matsuo; Yasuhiko Nagano; Itaru Endo
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

7.  Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Authors:  René Adam; Valérie Delvart; Gérard Pascal; Adrian Valeanu; Denis Castaing; Daniel Azoulay; Sylvie Giacchetti; Bernard Paule; Francis Kunstlinger; Odile Ghémard; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report.

Authors:  Norma Malavasi; Giovanni Ponti; Roberta Depenni; Federica Bertolini; Sandra Zironi; Gabriele Luppi; Pier Franco Conte
Journal:  J Hematol Oncol       Date:  2009-08-06       Impact factor: 17.388

9.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

10.  Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

Authors:  René Adam; Dennis A Wicherts; Robbert J de Haas; Thomas Aloia; Francis Lévi; Bernard Paule; Catherine Guettier; Francis Kunstlinger; Valérie Delvart; Daniel Azoulay; Denis Castaing
Journal:  J Clin Oncol       Date:  2008-04-01       Impact factor: 44.544

View more
  2 in total

1.  Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Christos Dervenis; Evaghelos Xynos; George Sotiropoulos; Nikolaos Gouvas; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Evangelia Chrysou; Christos Emmanouilidis; Panagiotis Georgiou; Niki Karachaliou; Ourania Katopodi; Panteleimon Kountourakis; Ioannis Kyriazanos; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Paris Tekkis; Charina Triantopoulou; Maria Tzardi; Vassilis Vassiliou; Louiza Vini; Spyridon Xynogalos; Nikolaos Ziras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016-06-03

2.  Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases.

Authors:  V Kepenekian; A Muller; P J Valette; P Rousset; M Chauvenet; G Phelip; T Walter; M Adham; O Glehen; G Passot
Journal:  BJS Open       Date:  2019-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.